Article Contents ::

Details About Generic Salt ::  Polyethy

Main Medicine Class:: Laxative   

(poli-eth-uh-leen gli-cawl)
CoLyte, GoLYTELY, Klean-Prep, OCL
Class: Laxative

 

Action Induces diarrhea, which rapidly cleanses bowel, usually within 4 hr.

 

Indications Bowel cleansing prior to GI examination. Unlabeled use(s): Management of acute iron overdose in children.

 

Contraindications GI obstruction; gastric retention; bowel perforation; toxic colitis; toxic megacolon or ileus.

 

Route/Dosage

ADULTS: PO/Nasogastric 4 L prior to GI examination. Give orally as 240 ml q 10 min or via NG tube as 1.2 to 1.8 L/hr until 4 L are consumed or until rectal effluent is clear. Via nasogastric (NG) tube, use rate of 1.2 to 1.8 L/hr.

 

Interactions

Oral medication given within 1 hr of starting therapy: Medication may be flushed from GI tract and not absorbed.

 

Lab Test Interferences None well documented.

 

Adverse Reactions

DERM: Urticaria; dermatitis. EENT: Rhinorrhea. GI: Nausea; abdominal fullness; bloating; abdominal cramps; vomiting; anal irritation.

 

Precautions

Pregnancy: Category C. Children: Safety and efficacy not established. Regurgitation/Aspiration: Use with caution in patients with impaired gag reflex. Severe ulcerative colitis: Use with caution. If GI obstruction or perforation is suspected, rule out these contraindications before administration.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • May be given via NG tube for patients unable or unwilling to drink solution.
  • Reconstitute solution with tap water and shake container until powder is dissolved.
  • Do not add flavorings or additional ingredients to solution before use. Chilling solution before administration improves palatability.
  • Refrigerate reconstituted solution. Use within 48 hr.
  • Administer minimum of 3 L of solution to achieve satisfactory bowel evacuation.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any allergies. Note history of ulcerative colitis.
  • Do not administer if patient has, or is suspected to have, GI obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon, or ileus.
  • Observe patients with impaired gag reflex or patient who is otherwise prone to regurgitation or aspiration during administration, especially if solution is given via NG tube.
  • Notify physician if patient is unable to tolerate solution or if rectal bleeding occurs.
  • If patient complains of bloating, abdominal pain or distention, slow solution or discontinue until symptoms abate.
OVERDOSAGE: SIGNS & SYMPTOMS
  Diarrhea, bloating, abdominal pain

 

Patient/Family Education

  • Explain that solution is given to cleanse bowel as preparation for GI examination.
  • Explain that if discomfort becomes intolerable, patient should stop drinking solution temporarily or allow longer intervals between drink portions.
  • Instruct patient not to eat or drink anything for 3 to 4 hr before ingestion and explain that only clear liquids are allowed after ingestion of solution.
  • Tell patient to continue drinking solution until watery stool is clear and free of solid material.
  • Instruct patient to report the following symptoms to physician: Severe bloating, distention, or abdominal pain.

 

Drugs Class ::

(poli-eth-uh-leen gli-cawl)
CoLyte, GoLYTELY, Klean-Prep, OCL
Class: Laxative

 

Action Induces diarrhea, which rapidly cleanses bowel, usually within 4 hr.

 

Indications Bowel cleansing prior to GI examination. Unlabeled use(s): Management of acute iron overdose in children.

 

Contraindications GI obstruction; gastric retention; bowel perforation; toxic colitis; toxic megacolon or ileus.

 

Route/Dosage

ADULTS: PO/Nasogastric 4 L prior to GI examination. Give orally as 240 ml q 10 min or via NG tube as 1.2 to 1.8 L/hr until 4 L are consumed or until rectal effluent is clear. Via nasogastric (NG) tube, use rate of 1.2 to 1.8 L/hr.

 

Interactions

Oral medication given within 1 hr of starting therapy: Medication may be flushed from GI tract and not absorbed.

 

Lab Test Interferences None well documented.

 

Adverse Reactions

DERM: Urticaria; dermatitis. EENT: Rhinorrhea. GI: Nausea; abdominal fullness; bloating; abdominal cramps; vomiting; anal irritation.

 

Precautions

Pregnancy: Category C. Children: Safety and efficacy not established. Regurgitation/Aspiration: Use with caution in patients with impaired gag reflex. Severe ulcerative colitis: Use with caution. If GI obstruction or perforation is suspected, rule out these contraindications before administration.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • May be given via NG tube for patients unable or unwilling to drink solution.
  • Reconstitute solution with tap water and shake container until powder is dissolved.
  • Do not add flavorings or additional ingredients to solution before use. Chilling solution before administration improves palatability.
  • Refrigerate reconstituted solution. Use within 48 hr.
  • Administer minimum of 3 L of solution to achieve satisfactory bowel evacuation.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any allergies. Note history of ulcerative colitis.
  • Do not administer if patient has, or is suspected to have, GI obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon, or ileus.
  • Observe patients with impaired gag reflex or patient who is otherwise prone to regurgitation or aspiration during administration, especially if solution is given via NG tube.
  • Notify physician if patient is unable to tolerate solution or if rectal bleeding occurs.
  • If patient complains of bloating, abdominal pain or distention, slow solution or discontinue until symptoms abate.
OVERDOSAGE: SIGNS & SYMPTOMS
  Diarrhea, bloating, abdominal pain

 

Patient/Family Education

  • Explain that solution is given to cleanse bowel as preparation for GI examination.
  • Explain that if discomfort becomes intolerable, patient should stop drinking solution temporarily or allow longer intervals between drink portions.
  • Instruct patient not to eat or drink anything for 3 to 4 hr before ingestion and explain that only clear liquids are allowed after ingestion of solution.
  • Tell patient to continue drinking solution until watery stool is clear and free of solid material.
  • Instruct patient to report the following symptoms to physician: Severe bloating, distention, or abdominal pain.

Indications for Drugs ::

(poli-eth-uh-leen gli-cawl)
CoLyte, GoLYTELY, Klean-Prep, OCL
Class: Laxative

 

Action Induces diarrhea, which rapidly cleanses bowel, usually within 4 hr.

 

Indications Bowel cleansing prior to GI examination. Unlabeled use(s): Management of acute iron overdose in children.

 

Contraindications GI obstruction; gastric retention; bowel perforation; toxic colitis; toxic megacolon or ileus.

 

Route/Dosage

ADULTS: PO/Nasogastric 4 L prior to GI examination. Give orally as 240 ml q 10 min or via NG tube as 1.2 to 1.8 L/hr until 4 L are consumed or until rectal effluent is clear. Via nasogastric (NG) tube, use rate of 1.2 to 1.8 L/hr.

 

Interactions

Oral medication given within 1 hr of starting therapy: Medication may be flushed from GI tract and not absorbed.

 

Lab Test Interferences None well documented.

 

Adverse Reactions

DERM: Urticaria; dermatitis. EENT: Rhinorrhea. GI: Nausea; abdominal fullness; bloating; abdominal cramps; vomiting; anal irritation.

 

Precautions

Pregnancy: Category C. Children: Safety and efficacy not established. Regurgitation/Aspiration: Use with caution in patients with impaired gag reflex. Severe ulcerative colitis: Use with caution. If GI obstruction or perforation is suspected, rule out these contraindications before administration.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • May be given via NG tube for patients unable or unwilling to drink solution.
  • Reconstitute solution with tap water and shake container until powder is dissolved.
  • Do not add flavorings or additional ingredients to solution before use. Chilling solution before administration improves palatability.
  • Refrigerate reconstituted solution. Use within 48 hr.
  • Administer minimum of 3 L of solution to achieve satisfactory bowel evacuation.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any allergies. Note history of ulcerative colitis.
  • Do not administer if patient has, or is suspected to have, GI obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon, or ileus.
  • Observe patients with impaired gag reflex or patient who is otherwise prone to regurgitation or aspiration during administration, especially if solution is given via NG tube.
  • Notify physician if patient is unable to tolerate solution or if rectal bleeding occurs.
  • If patient complains of bloating, abdominal pain or distention, slow solution or discontinue until symptoms abate.
OVERDOSAGE: SIGNS & SYMPTOMS
  Diarrhea, bloating, abdominal pain

 

Patient/Family Education

  • Explain that solution is given to cleanse bowel as preparation for GI examination.
  • Explain that if discomfort becomes intolerable, patient should stop drinking solution temporarily or allow longer intervals between drink portions.
  • Instruct patient not to eat or drink anything for 3 to 4 hr before ingestion and explain that only clear liquids are allowed after ingestion of solution.
  • Tell patient to continue drinking solution until watery stool is clear and free of solid material.
  • Instruct patient to report the following symptoms to physician: Severe bloating, distention, or abdominal pain.

Drug Dose ::

(poli-eth-uh-leen gli-cawl)
CoLyte, GoLYTELY, Klean-Prep, OCL
Class: Laxative

 

Action Induces diarrhea, which rapidly cleanses bowel, usually within 4 hr.

 

Indications Bowel cleansing prior to GI examination. Unlabeled use(s): Management of acute iron overdose in children.

 

Contraindications GI obstruction; gastric retention; bowel perforation; toxic colitis; toxic megacolon or ileus.

 

Route/Dosage

ADULTS: PO/Nasogastric 4 L prior to GI examination. Give orally as 240 ml q 10 min or via NG tube as 1.2 to 1.8 L/hr until 4 L are consumed or until rectal effluent is clear. Via nasogastric (NG) tube, use rate of 1.2 to 1.8 L/hr.

 

Interactions

Oral medication given within 1 hr of starting therapy: Medication may be flushed from GI tract and not absorbed.

 

Lab Test Interferences None well documented.

 

Adverse Reactions

DERM: Urticaria; dermatitis. EENT: Rhinorrhea. GI: Nausea; abdominal fullness; bloating; abdominal cramps; vomiting; anal irritation.

 

Precautions

Pregnancy: Category C. Children: Safety and efficacy not established. Regurgitation/Aspiration: Use with caution in patients with impaired gag reflex. Severe ulcerative colitis: Use with caution. If GI obstruction or perforation is suspected, rule out these contraindications before administration.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • May be given via NG tube for patients unable or unwilling to drink solution.
  • Reconstitute solution with tap water and shake container until powder is dissolved.
  • Do not add flavorings or additional ingredients to solution before use. Chilling solution before administration improves palatability.
  • Refrigerate reconstituted solution. Use within 48 hr.
  • Administer minimum of 3 L of solution to achieve satisfactory bowel evacuation.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any allergies. Note history of ulcerative colitis.
  • Do not administer if patient has, or is suspected to have, GI obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon, or ileus.
  • Observe patients with impaired gag reflex or patient who is otherwise prone to regurgitation or aspiration during administration, especially if solution is given via NG tube.
  • Notify physician if patient is unable to tolerate solution or if rectal bleeding occurs.
  • If patient complains of bloating, abdominal pain or distention, slow solution or discontinue until symptoms abate.
OVERDOSAGE: SIGNS & SYMPTOMS
  Diarrhea, bloating, abdominal pain

 

Patient/Family Education

  • Explain that solution is given to cleanse bowel as preparation for GI examination.
  • Explain that if discomfort becomes intolerable, patient should stop drinking solution temporarily or allow longer intervals between drink portions.
  • Instruct patient not to eat or drink anything for 3 to 4 hr before ingestion and explain that only clear liquids are allowed after ingestion of solution.
  • Tell patient to continue drinking solution until watery stool is clear and free of solid material.
  • Instruct patient to report the following symptoms to physician: Severe bloating, distention, or abdominal pain.

Contraindication ::

(poli-eth-uh-leen gli-cawl)
CoLyte, GoLYTELY, Klean-Prep, OCL
Class: Laxative

 

Action Induces diarrhea, which rapidly cleanses bowel, usually within 4 hr.

 

Indications Bowel cleansing prior to GI examination. Unlabeled use(s): Management of acute iron overdose in children.

 

Contraindications GI obstruction; gastric retention; bowel perforation; toxic colitis; toxic megacolon or ileus.

 

Route/Dosage

ADULTS: PO/Nasogastric 4 L prior to GI examination. Give orally as 240 ml q 10 min or via NG tube as 1.2 to 1.8 L/hr until 4 L are consumed or until rectal effluent is clear. Via nasogastric (NG) tube, use rate of 1.2 to 1.8 L/hr.

 

Interactions

Oral medication given within 1 hr of starting therapy: Medication may be flushed from GI tract and not absorbed.

 

Lab Test Interferences None well documented.

 

Adverse Reactions

DERM: Urticaria; dermatitis. EENT: Rhinorrhea. GI: Nausea; abdominal fullness; bloating; abdominal cramps; vomiting; anal irritation.

 

Precautions

Pregnancy: Category C. Children: Safety and efficacy not established. Regurgitation/Aspiration: Use with caution in patients with impaired gag reflex. Severe ulcerative colitis: Use with caution. If GI obstruction or perforation is suspected, rule out these contraindications before administration.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • May be given via NG tube for patients unable or unwilling to drink solution.
  • Reconstitute solution with tap water and shake container until powder is dissolved.
  • Do not add flavorings or additional ingredients to solution before use. Chilling solution before administration improves palatability.
  • Refrigerate reconstituted solution. Use within 48 hr.
  • Administer minimum of 3 L of solution to achieve satisfactory bowel evacuation.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any allergies. Note history of ulcerative colitis.
  • Do not administer if patient has, or is suspected to have, GI obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon, or ileus.
  • Observe patients with impaired gag reflex or patient who is otherwise prone to regurgitation or aspiration during administration, especially if solution is given via NG tube.
  • Notify physician if patient is unable to tolerate solution or if rectal bleeding occurs.
  • If patient complains of bloating, abdominal pain or distention, slow solution or discontinue until symptoms abate.
OVERDOSAGE: SIGNS & SYMPTOMS
  Diarrhea, bloating, abdominal pain

 

Patient/Family Education

  • Explain that solution is given to cleanse bowel as preparation for GI examination.
  • Explain that if discomfort becomes intolerable, patient should stop drinking solution temporarily or allow longer intervals between drink portions.
  • Instruct patient not to eat or drink anything for 3 to 4 hr before ingestion and explain that only clear liquids are allowed after ingestion of solution.
  • Tell patient to continue drinking solution until watery stool is clear and free of solid material.
  • Instruct patient to report the following symptoms to physician: Severe bloating, distention, or abdominal pain.

Drug Precautions ::

(poli-eth-uh-leen gli-cawl)
CoLyte, GoLYTELY, Klean-Prep, OCL
Class: Laxative

 

Action Induces diarrhea, which rapidly cleanses bowel, usually within 4 hr.

 

Indications Bowel cleansing prior to GI examination. Unlabeled use(s): Management of acute iron overdose in children.

 

Contraindications GI obstruction; gastric retention; bowel perforation; toxic colitis; toxic megacolon or ileus.

 

Route/Dosage

ADULTS: PO/Nasogastric 4 L prior to GI examination. Give orally as 240 ml q 10 min or via NG tube as 1.2 to 1.8 L/hr until 4 L are consumed or until rectal effluent is clear. Via nasogastric (NG) tube, use rate of 1.2 to 1.8 L/hr.

 

Interactions

Oral medication given within 1 hr of starting therapy: Medication may be flushed from GI tract and not absorbed.

 

Lab Test Interferences None well documented.

 

Adverse Reactions

DERM: Urticaria; dermatitis. EENT: Rhinorrhea. GI: Nausea; abdominal fullness; bloating; abdominal cramps; vomiting; anal irritation.

 

Precautions

Pregnancy: Category C. Children: Safety and efficacy not established. Regurgitation/Aspiration: Use with caution in patients with impaired gag reflex. Severe ulcerative colitis: Use with caution. If GI obstruction or perforation is suspected, rule out these contraindications before administration.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • May be given via NG tube for patients unable or unwilling to drink solution.
  • Reconstitute solution with tap water and shake container until powder is dissolved.
  • Do not add flavorings or additional ingredients to solution before use. Chilling solution before administration improves palatability.
  • Refrigerate reconstituted solution. Use within 48 hr.
  • Administer minimum of 3 L of solution to achieve satisfactory bowel evacuation.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any allergies. Note history of ulcerative colitis.
  • Do not administer if patient has, or is suspected to have, GI obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon, or ileus.
  • Observe patients with impaired gag reflex or patient who is otherwise prone to regurgitation or aspiration during administration, especially if solution is given via NG tube.
  • Notify physician if patient is unable to tolerate solution or if rectal bleeding occurs.
  • If patient complains of bloating, abdominal pain or distention, slow solution or discontinue until symptoms abate.
OVERDOSAGE: SIGNS & SYMPTOMS
  Diarrhea, bloating, abdominal pain

 

Patient/Family Education

  • Explain that solution is given to cleanse bowel as preparation for GI examination.
  • Explain that if discomfort becomes intolerable, patient should stop drinking solution temporarily or allow longer intervals between drink portions.
  • Instruct patient not to eat or drink anything for 3 to 4 hr before ingestion and explain that only clear liquids are allowed after ingestion of solution.
  • Tell patient to continue drinking solution until watery stool is clear and free of solid material.
  • Instruct patient to report the following symptoms to physician: Severe bloating, distention, or abdominal pain.

Drug Side Effects ::

(poli-eth-uh-leen gli-cawl)
CoLyte, GoLYTELY, Klean-Prep, OCL
Class: Laxative

 

Action Induces diarrhea, which rapidly cleanses bowel, usually within 4 hr.

 

Indications Bowel cleansing prior to GI examination. Unlabeled use(s): Management of acute iron overdose in children.

 

Contraindications GI obstruction; gastric retention; bowel perforation; toxic colitis; toxic megacolon or ileus.

 

Route/Dosage

ADULTS: PO/Nasogastric 4 L prior to GI examination. Give orally as 240 ml q 10 min or via NG tube as 1.2 to 1.8 L/hr until 4 L are consumed or until rectal effluent is clear. Via nasogastric (NG) tube, use rate of 1.2 to 1.8 L/hr.

 

Interactions

Oral medication given within 1 hr of starting therapy: Medication may be flushed from GI tract and not absorbed.

 

Lab Test Interferences None well documented.

 

Adverse Reactions

DERM: Urticaria; dermatitis. EENT: Rhinorrhea. GI: Nausea; abdominal fullness; bloating; abdominal cramps; vomiting; anal irritation.

 

Precautions

Pregnancy: Category C. Children: Safety and efficacy not established. Regurgitation/Aspiration: Use with caution in patients with impaired gag reflex. Severe ulcerative colitis: Use with caution. If GI obstruction or perforation is suspected, rule out these contraindications before administration.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • May be given via NG tube for patients unable or unwilling to drink solution.
  • Reconstitute solution with tap water and shake container until powder is dissolved.
  • Do not add flavorings or additional ingredients to solution before use. Chilling solution before administration improves palatability.
  • Refrigerate reconstituted solution. Use within 48 hr.
  • Administer minimum of 3 L of solution to achieve satisfactory bowel evacuation.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any allergies. Note history of ulcerative colitis.
  • Do not administer if patient has, or is suspected to have, GI obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon, or ileus.
  • Observe patients with impaired gag reflex or patient who is otherwise prone to regurgitation or aspiration during administration, especially if solution is given via NG tube.
  • Notify physician if patient is unable to tolerate solution or if rectal bleeding occurs.
  • If patient complains of bloating, abdominal pain or distention, slow solution or discontinue until symptoms abate.
OVERDOSAGE: SIGNS & SYMPTOMS
  Diarrhea, bloating, abdominal pain

 

Patient/Family Education

  • Explain that solution is given to cleanse bowel as preparation for GI examination.
  • Explain that if discomfort becomes intolerable, patient should stop drinking solution temporarily or allow longer intervals between drink portions.
  • Instruct patient not to eat or drink anything for 3 to 4 hr before ingestion and explain that only clear liquids are allowed after ingestion of solution.
  • Tell patient to continue drinking solution until watery stool is clear and free of solid material.
  • Instruct patient to report the following symptoms to physician: Severe bloating, distention, or abdominal pain.

Drug Mode of Action ::  

(poli-eth-uh-leen gli-cawl)
CoLyte, GoLYTELY, Klean-Prep, OCL
Class: Laxative

 

Action Induces diarrhea, which rapidly cleanses bowel, usually within 4 hr.

 

Indications Bowel cleansing prior to GI examination. Unlabeled use(s): Management of acute iron overdose in children.

 

Contraindications GI obstruction; gastric retention; bowel perforation; toxic colitis; toxic megacolon or ileus.

 

Route/Dosage

ADULTS: PO/Nasogastric 4 L prior to GI examination. Give orally as 240 ml q 10 min or via NG tube as 1.2 to 1.8 L/hr until 4 L are consumed or until rectal effluent is clear. Via nasogastric (NG) tube, use rate of 1.2 to 1.8 L/hr.

 

Interactions

Oral medication given within 1 hr of starting therapy: Medication may be flushed from GI tract and not absorbed.

 

Lab Test Interferences None well documented.

 

Adverse Reactions

DERM: Urticaria; dermatitis. EENT: Rhinorrhea. GI: Nausea; abdominal fullness; bloating; abdominal cramps; vomiting; anal irritation.

 

Precautions

Pregnancy: Category C. Children: Safety and efficacy not established. Regurgitation/Aspiration: Use with caution in patients with impaired gag reflex. Severe ulcerative colitis: Use with caution. If GI obstruction or perforation is suspected, rule out these contraindications before administration.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • May be given via NG tube for patients unable or unwilling to drink solution.
  • Reconstitute solution with tap water and shake container until powder is dissolved.
  • Do not add flavorings or additional ingredients to solution before use. Chilling solution before administration improves palatability.
  • Refrigerate reconstituted solution. Use within 48 hr.
  • Administer minimum of 3 L of solution to achieve satisfactory bowel evacuation.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any allergies. Note history of ulcerative colitis.
  • Do not administer if patient has, or is suspected to have, GI obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon, or ileus.
  • Observe patients with impaired gag reflex or patient who is otherwise prone to regurgitation or aspiration during administration, especially if solution is given via NG tube.
  • Notify physician if patient is unable to tolerate solution or if rectal bleeding occurs.
  • If patient complains of bloating, abdominal pain or distention, slow solution or discontinue until symptoms abate.
OVERDOSAGE: SIGNS & SYMPTOMS
  Diarrhea, bloating, abdominal pain

 

Patient/Family Education

  • Explain that solution is given to cleanse bowel as preparation for GI examination.
  • Explain that if discomfort becomes intolerable, patient should stop drinking solution temporarily or allow longer intervals between drink portions.
  • Instruct patient not to eat or drink anything for 3 to 4 hr before ingestion and explain that only clear liquids are allowed after ingestion of solution.
  • Tell patient to continue drinking solution until watery stool is clear and free of solid material.
  • Instruct patient to report the following symptoms to physician: Severe bloating, distention, or abdominal pain.

Drug Interactions ::

(poli-eth-uh-leen gli-cawl)
CoLyte, GoLYTELY, Klean-Prep, OCL
Class: Laxative

 

Action Induces diarrhea, which rapidly cleanses bowel, usually within 4 hr.

 

Indications Bowel cleansing prior to GI examination. Unlabeled use(s): Management of acute iron overdose in children.

 

Contraindications GI obstruction; gastric retention; bowel perforation; toxic colitis; toxic megacolon or ileus.

 

Route/Dosage

ADULTS: PO/Nasogastric 4 L prior to GI examination. Give orally as 240 ml q 10 min or via NG tube as 1.2 to 1.8 L/hr until 4 L are consumed or until rectal effluent is clear. Via nasogastric (NG) tube, use rate of 1.2 to 1.8 L/hr.

 

Interactions

Oral medication given within 1 hr of starting therapy: Medication may be flushed from GI tract and not absorbed.

 

Drug Assesment ::

(poli-eth-uh-leen gli-cawl)
CoLyte, GoLYTELY, Klean-Prep, OCL
Class: Laxative

 

Action Induces diarrhea, which rapidly cleanses bowel, usually within 4 hr.

 

Indications Bowel cleansing prior to GI examination. Unlabeled use(s): Management of acute iron overdose in children.

 

Contraindications GI obstruction; gastric retention; bowel perforation; toxic colitis; toxic megacolon or ileus.

 

Route/Dosage

ADULTS: PO/Nasogastric 4 L prior to GI examination. Give orally as 240 ml q 10 min or via NG tube as 1.2 to 1.8 L/hr until 4 L are consumed or until rectal effluent is clear. Via nasogastric (NG) tube, use rate of 1.2 to 1.8 L/hr.

 

Interactions

Oral medication given within 1 hr of starting therapy: Medication may be flushed from GI tract and not absorbed.

 

Lab Test Interferences None well documented.

 

Adverse Reactions

DERM: Urticaria; dermatitis. EENT: Rhinorrhea. GI: Nausea; abdominal fullness; bloating; abdominal cramps; vomiting; anal irritation.

 

Precautions

Pregnancy: Category C. Children: Safety and efficacy not established. Regurgitation/Aspiration: Use with caution in patients with impaired gag reflex. Severe ulcerative colitis: Use with caution. If GI obstruction or perforation is suspected, rule out these contraindications before administration.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • May be given via NG tube for patients unable or unwilling to drink solution.
  • Reconstitute solution with tap water and shake container until powder is dissolved.
  • Do not add flavorings or additional ingredients to solution before use. Chilling solution before administration improves palatability.
  • Refrigerate reconstituted solution. Use within 48 hr.
  • Administer minimum of 3 L of solution to achieve satisfactory bowel evacuation.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any allergies. Note history of ulcerative colitis.
  • Do not administer if patient has, or is suspected to have, GI obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon, or ileus.
  • Observe patients with impaired gag reflex or patient who is otherwise prone to regurgitation or aspiration during administration, especially if solution is given via NG tube.
  • Notify physician if patient is unable to tolerate solution or if rectal bleeding occurs.
  • If patient complains of bloating, abdominal pain or distention, slow solution or discontinue until symptoms abate.
OVERDOSAGE: SIGNS & SYMPTOMS
  Diarrhea, bloating, abdominal pain

 

Patient/Family Education

  • Explain that solution is given to cleanse bowel as preparation for GI examination.
  • Explain that if discomfort becomes intolerable, patient should stop drinking solution temporarily or allow longer intervals between drink portions.
  • Instruct patient not to eat or drink anything for 3 to 4 hr before ingestion and explain that only clear liquids are allowed after ingestion of solution.
  • Tell patient to continue drinking solution until watery stool is clear and free of solid material.
  • Instruct patient to report the following symptoms to physician: Severe bloating, distention, or abdominal pain.

Drug Storage/Management ::

(poli-eth-uh-leen gli-cawl)
CoLyte, GoLYTELY, Klean-Prep, OCL
Class: Laxative

 

Action Induces diarrhea, which rapidly cleanses bowel, usually within 4 hr.

 

Indications Bowel cleansing prior to GI examination. Unlabeled use(s): Management of acute iron overdose in children.

 

Contraindications GI obstruction; gastric retention; bowel perforation; toxic colitis; toxic megacolon or ileus.

 

Route/Dosage

ADULTS: PO/Nasogastric 4 L prior to GI examination. Give orally as 240 ml q 10 min or via NG tube as 1.2 to 1.8 L/hr until 4 L are consumed or until rectal effluent is clear. Via nasogastric (NG) tube, use rate of 1.2 to 1.8 L/hr.

 

Interactions

Oral medication given within 1 hr of starting therapy: Medication may be flushed from GI tract and not absorbed.

 

Lab Test Interferences None well documented.

 

Adverse Reactions

DERM: Urticaria; dermatitis. EENT: Rhinorrhea. GI: Nausea; abdominal fullness; bloating; abdominal cramps; vomiting; anal irritation.

 

Precautions

Pregnancy: Category C. Children: Safety and efficacy not established. Regurgitation/Aspiration: Use with caution in patients with impaired gag reflex. Severe ulcerative colitis: Use with caution. If GI obstruction or perforation is suspected, rule out these contraindications before administration.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • May be given via NG tube for patients unable or unwilling to drink solution.
  • Reconstitute solution with tap water and shake container until powder is dissolved.
  • Do not add flavorings or additional ingredients to solution before use. Chilling solution before administration improves palatability.
  • Refrigerate reconstituted solution. Use within 48 hr.
  • Administer minimum of 3 L of solution to achieve satisfactory bowel evacuation.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any allergies. Note history of ulcerative colitis.
  • Do not administer if patient has, or is suspected to have, GI obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon, or ileus.
  • Observe patients with impaired gag reflex or patient who is otherwise prone to regurgitation or aspiration during administration, especially if solution is given via NG tube.
  • Notify physician if patient is unable to tolerate solution or if rectal bleeding occurs.
  • If patient complains of bloating, abdominal pain or distention, slow solution or discontinue until symptoms abate.
OVERDOSAGE: SIGNS & SYMPTOMS
  Diarrhea, bloating, abdominal pain

 

Patient/Family Education

  • Explain that solution is given to cleanse bowel as preparation for GI examination.
  • Explain that if discomfort becomes intolerable, patient should stop drinking solution temporarily or allow longer intervals between drink portions.
  • Instruct patient not to eat or drink anything for 3 to 4 hr before ingestion and explain that only clear liquids are allowed after ingestion of solution.
  • Tell patient to continue drinking solution until watery stool is clear and free of solid material.
  • Instruct patient to report the following symptoms to physician: Severe bloating, distention, or abdominal pain.

Drug Notes ::

(poli-eth-uh-leen gli-cawl)
CoLyte, GoLYTELY, Klean-Prep, OCL
Class: Laxative

 

Action Induces diarrhea, which rapidly cleanses bowel, usually within 4 hr.

 

Indications Bowel cleansing prior to GI examination. Unlabeled use(s): Management of acute iron overdose in children.

 

Contraindications GI obstruction; gastric retention; bowel perforation; toxic colitis; toxic megacolon or ileus.

 

Route/Dosage

ADULTS: PO/Nasogastric 4 L prior to GI examination. Give orally as 240 ml q 10 min or via NG tube as 1.2 to 1.8 L/hr until 4 L are consumed or until rectal effluent is clear. Via nasogastric (NG) tube, use rate of 1.2 to 1.8 L/hr.

 

Interactions

Oral medication given within 1 hr of starting therapy: Medication may be flushed from GI tract and not absorbed.

 

Lab Test Interferences None well documented.

 

Adverse Reactions

DERM: Urticaria; dermatitis. EENT: Rhinorrhea. GI: Nausea; abdominal fullness; bloating; abdominal cramps; vomiting; anal irritation.

 

Precautions

Pregnancy: Category C. Children: Safety and efficacy not established. Regurgitation/Aspiration: Use with caution in patients with impaired gag reflex. Severe ulcerative colitis: Use with caution. If GI obstruction or perforation is suspected, rule out these contraindications before administration.

PATIENT CARE CONSIDERATIONS


 

Administration/Storage

  • May be given via NG tube for patients unable or unwilling to drink solution.
  • Reconstitute solution with tap water and shake container until powder is dissolved.
  • Do not add flavorings or additional ingredients to solution before use. Chilling solution before administration improves palatability.
  • Refrigerate reconstituted solution. Use within 48 hr.
  • Administer minimum of 3 L of solution to achieve satisfactory bowel evacuation.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any allergies. Note history of ulcerative colitis.
  • Do not administer if patient has, or is suspected to have, GI obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon, or ileus.
  • Observe patients with impaired gag reflex or patient who is otherwise prone to regurgitation or aspiration during administration, especially if solution is given via NG tube.
  • Notify physician if patient is unable to tolerate solution or if rectal bleeding occurs.
  • If patient complains of bloating, abdominal pain or distention, slow solution or discontinue until symptoms abate.
OVERDOSAGE: SIGNS & SYMPTOMS
  Diarrhea, bloating, abdominal pain

 

Patient/Family Education

  • Explain that solution is given to cleanse bowel as preparation for GI examination.
  • Explain that if discomfort becomes intolerable, patient should stop drinking solution temporarily or allow longer intervals between drink portions.
  • Instruct patient not to eat or drink anything for 3 to 4 hr before ingestion and explain that only clear liquids are allowed after ingestion of solution.
  • Tell patient to continue drinking solution until watery stool is clear and free of solid material.
  • Instruct patient to report the following symptoms to physician: Severe bloating, distention, or abdominal pain.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.